Kim Nguyen Lee
About Kim Nguyen Lee
Kim Nguyen Lee is the Early Assets Lead for WW Hematology Commercialization, Multiple Myeloma at Bristol Myers Squibb in Summit, New Jersey. She has extensive experience in medical affairs, clinical study monitoring, and strategic planning within the hematology field.
Current Role at Bristol Myers Squibb
Kim Nguyen Lee serves as the Early Assets Lead for Worldwide Hematology Commercialization, Multiple Myeloma at Bristol Myers Squibb. Based in Summit, New Jersey, Kim focuses on driving the strategic direction and commercialization of early-stage assets in the hematology market, particularly in multiple myeloma. This role involves close collaboration with various stakeholders to ensure the effective transition of medical products from development to market.
Previous Experience at Bristol Myers Squibb
Before her current position, Kim Nguyen Lee was the Director of US Medical Affairs for Multiple Myeloma at Bristol Myers Squibb from 2020 to 2022. During her tenure, she led the development and implementation of medical strategies to support the commercialization of multiple myeloma products in the US. Additionally, she played an instrumental role in aligning medical and commercial objectives, optimizing clinical and strategic outcomes within the hematology division.
Roles at Celgene
Kim Nguyen Lee held significant positions at Celgene, including Director and Function Lead for Global Medical Content from 2018 to 2020 and Director and Team Lead for Global Medical Information from 2015 to 2018. Her responsibilities involved the creation and dissemination of scientific content, the development of strategic plans for medical information, and working collaboratively with thought leaders to advance medical knowledge in the field of hematology.
Career at Pfizer
Kim Nguyen Lee's career at Pfizer spanned from 2004 to 2015, where she held various roles, including Director/Payer Lead for Global Medical Information, Medical Director in US Medical Affairs, and Senior Safety Surveillance Associate in Safety and Risk Management. Her work included medical monitoring of clinical trials, ensuring the safety and efficacy of pharmaceutical products, and optimizing medical processes within the organization. Her tenure at Pfizer also included a secondment as a Medical Director, highlighting her extensive experience in medical affairs.
Education at Rutgers University
Kim Nguyen Lee completed her Pharm.D. at Rutgers University, where she studied Pharmacy from 1998 to 2004. This six-year program provided her with a strong foundation in pharmaceutical sciences, clinical practice, and medical knowledge, equipping her with the skills necessary for her extensive career in the medical field. Her academic background laid the groundwork for her subsequent roles in medical affairs and commercialization within the pharmaceutical industry.